Pharmaceuticals

Global Vaccine Adjuvants Market Overview: Trends Shaping Growth to 2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Vaccine Adjuvants Industry Expected To Reach By 2029, Starting From 2025 Levels?

The vaccine adjuvants market has experienced robust expansion over recent years. Projections indicate it will expand from $1.89 billion in 2024 to reach $2.01 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. Historically, this expansion is linked to factors such as a rise in vaccine creation, the widespread occurrence of infectious diseases, governmental policies and vaccination drives, funding for research and development, and the worldwide distribution of vaccines.

The vaccine adjuvants market size is anticipated to experience robust expansion over the coming years. It is projected to reach $2.83 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.9%. This projected growth is largely due to factors such as pandemic preparedness, an expanding range of vaccines, global immunization objectives, strategic collaborations and partnerships, and an increased emphasis on therapeutic vaccines. Significant developments expected during this forecast period involve advancements in adjuvant technologies, a heightened focus on improving immunogenicity, the utilization of combination adjuvants for greater efficacy, a rising need for safer and well-tolerated adjuvants, and the emergence of personalized vaccines and adjuvants.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Which Drivers Are Impacting The Vaccine Adjuvants Market?

The growing incidence of infectious diseases is anticipated to fuel the expansion of the vaccine adjuvants market in the future. These diseases are characterized by infections stemming from viruses, bacteria, fungi, or parasites. To combat these infectious conditions, including hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis, vaccines are employed. Illustratively, data from the 2022 World Health Organization (WHO) report revealed that approximately 10.6 million individuals worldwide had tuberculosis in 2021, resulting in 1.6 million deaths, and concurrently, 1.5 million people contracted HIV in 2021, with 650,000 fatalities attributed to it. Consequently, the increasing occurrence of infectious diseases will stimulate the vaccine adjuvants market.

What Are The Leading Segments Analyzed In The Vaccine Adjuvants Market?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Which Competitive Trends Are Defining The Vaccine Adjuvants Market Structure?

Product innovations represent a key trend gaining traction in the vaccine adjuvants market. Companies operating within the vaccine adjuvants market are prioritizing the adoption of innovative solutions to strengthen their market position. For instance, in December 2022, Evonik Industries, a Germany-based chemical manufacturing company, unveiled PhytoSquene, a plant-based squalene extracted from amaranth oil. This sustainable alternative to conventional shark-derived squalene is engineered for application in vaccine adjuvants and other pharmaceutical uses, enhancing vaccine efficacy through improved immune responses. The introduction of PhytoSquene emphasizes the increasing focus on sustainability within the pharmaceutical sector.

Which Global Market Leaders Are Shaping The Future Of The Vaccine Adjuvants Sector?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

How Do Regional Market Performances Compare Within The Vaccine Adjuvants Industry?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Vaccine Adjuvants Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Browse Through More Reports Similar to the Global Vaccine Adjuvants Market 2025, By The Business Research Company

Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Ethylene Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ethylene-global-market-report

Genetically Modified Crops Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795